Revolution Medicines EPS Diluted (Quarterly) Trends

Revolution Medicines Inc (RVMD)

56.75 -0.03 (-0.05%) USD | NASDAQ | Nov 22, 16:00

58.96 +2.21 (+3.89%) After-Hours: 20:00

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
September 30, 2024	-0.94
June 30, 2024	-0.81
March 31, 2024	-0.70
December 31, 2023	-1.21
September 30, 2023	-0.99
June 30, 2023	-0.92
March 31, 2023	-0.72
December 31, 2022	-0.63
September 30, 2022	-0.87
June 30, 2022	-0.82
March 31, 2022	-0.78
December 31, 2021	-0.71

Date	Value
September 30, 2021	-0.72
June 30, 2021	-0.60
March 31, 2021	-0.53
December 31, 2020	-0.52
September 30, 2020	-0.42
June 30, 2020	-0.46
March 31, 2020	-0.74
December 31, 2019	-0.3563
September 30, 2019	-0.4679
June 30, 2019	-0.3614
March 31, 2019	-0.3511
December 31, 2018	-0.38

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-1.21

Minimum

Dec 2023

-0.3563

Maximum

Dec 2019

-0.7223

Average

-0.72

Median

Sep 2021

EPS Diluted (Quarterly) Benchmarks

Perspective Therapeutics Inc	-0.21
Electromed Inc	0.16
Xtant Medical Holdings Inc	-0.04
Myomo Inc	-0.03
Catheter Precision Inc	-2.01

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly)	-156.29M
Total Expenses (Quarterly)	175.71M
Enterprise Value	7.997B
Earnings Yield	-6.45%
Normalized Earnings Yield	-6.766